JP2024515705A5 - - Google Patents
Info
- Publication number
- JP2024515705A5 JP2024515705A5 JP2023564537A JP2023564537A JP2024515705A5 JP 2024515705 A5 JP2024515705 A5 JP 2024515705A5 JP 2023564537 A JP2023564537 A JP 2023564537A JP 2023564537 A JP2023564537 A JP 2023564537A JP 2024515705 A5 JP2024515705 A5 JP 2024515705A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- thiazole
- indole
- methyl
- acetamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21382343.8 | 2021-04-21 | ||
| EP21382343.8A EP4079304A1 (en) | 2021-04-21 | 2021-04-21 | Compounds for use in the treatment of hyperproliferative disorders |
| PCT/EP2022/060579 WO2022223704A1 (en) | 2021-04-21 | 2022-04-21 | Compounds for use in the treatment of hyperproliferative disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024515705A JP2024515705A (ja) | 2024-04-10 |
| JP2024515705A5 true JP2024515705A5 (enExample) | 2025-04-17 |
Family
ID=75674747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564537A Pending JP2024515705A (ja) | 2021-04-21 | 2022-04-21 | 過剰増殖性疾患の治療における使用のための化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240208998A1 (enExample) |
| EP (2) | EP4079304A1 (enExample) |
| JP (1) | JP2024515705A (enExample) |
| KR (1) | KR20240013112A (enExample) |
| CN (1) | CN117320715A (enExample) |
| AU (1) | AU2022260529A1 (enExample) |
| BR (1) | BR112023021959A2 (enExample) |
| CA (1) | CA3216090A1 (enExample) |
| IL (1) | IL307868A (enExample) |
| MX (1) | MX2023012457A (enExample) |
| WO (1) | WO2022223704A1 (enExample) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2609912T3 (es) * | 2007-06-22 | 2017-04-25 | Hydra Biosciences, Inc. | Compuestos de 2,6-dioxo, -2,3-dihidro-1h-purina útiles para el tratamiento de trastornos relacionados con la actividad del canal trpa1 |
-
2021
- 2021-04-21 EP EP21382343.8A patent/EP4079304A1/en not_active Withdrawn
-
2022
- 2022-04-21 CN CN202280035450.7A patent/CN117320715A/zh active Pending
- 2022-04-21 BR BR112023021959A patent/BR112023021959A2/pt unknown
- 2022-04-21 US US18/556,456 patent/US20240208998A1/en active Pending
- 2022-04-21 EP EP22723682.5A patent/EP4326262A1/en active Pending
- 2022-04-21 JP JP2023564537A patent/JP2024515705A/ja active Pending
- 2022-04-21 KR KR1020237040063A patent/KR20240013112A/ko active Pending
- 2022-04-21 WO PCT/EP2022/060579 patent/WO2022223704A1/en not_active Ceased
- 2022-04-21 IL IL307868A patent/IL307868A/en unknown
- 2022-04-21 MX MX2023012457A patent/MX2023012457A/es unknown
- 2022-04-21 AU AU2022260529A patent/AU2022260529A1/en active Pending
- 2022-04-21 CA CA3216090A patent/CA3216090A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mishra et al. | A retrospect on antimicrobial potential of thiazole scaffold | |
| Arora et al. | 2, 4-Disubstituted thiazoles as multitargated bioactive molecules | |
| T. Chhabria et al. | Thiazole: A review on chemistry, synthesis and therapeutic importance of its derivatives | |
| AU2017254523B2 (en) | Compounds and compositions for treating conditions associated with NLRP activity | |
| CN101677563B (zh) | 5,6-二氢-1h-吡啶-2-酮化合物 | |
| US8431604B2 (en) | Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors | |
| ES2545489T3 (es) | Compuestos de amido-tiofeno y su uso | |
| JP2007505933A5 (enExample) | ||
| TW200524575A (en) | Biaryl linked hydroxamates: preparation and pharmaceutical applications | |
| JP2019503362A5 (enExample) | ||
| JP2010534647A5 (enExample) | ||
| JP2011529504A5 (enExample) | ||
| JP2006513192A5 (enExample) | ||
| JP2010536740A5 (enExample) | ||
| JP2007520440A5 (enExample) | ||
| CN101137651A (zh) | 哒嗪酮化合物 | |
| RU2007128624A (ru) | Производные пиразол-пиримидина в качестве антагонистов mglur2 | |
| JP6967000B2 (ja) | セフェム系化合物、それらの生成および使用 | |
| CN114080389B (zh) | Nrf2活性化化合物 | |
| Faidallah et al. | Synthesis and biological evaluation of some novel urea and thiourea derivatives of isoxazolo [4, 5-d] pyridazine and structurally related thiazolo [4, 5-d] pyridazine as antimicrobial agents | |
| Lahsasni et al. | Synthesis, Characterization, and Antibacterial and Anti‐Inflammatory Activities of New Pyrimidine and Thiophene Derivatives | |
| JP2007503432A5 (enExample) | ||
| JP2024515705A5 (enExample) | ||
| PL176471B1 (pl) | Nowe pochodne (1-heteroazolilo-1-heterocyklo)alkanów, sposób ich wytwarzania i kompozycja farmaceutyczna je zawierająca | |
| KR20020002394A (ko) | 비만증 예방 또는 치료용 약제를 제조하기 위한,폴리사이클릭 2-아미노-티아졸계의 용도 |